High‐Load Gemcitabine Inorganic–Organic Hybrid Nanoparticles as an Image‐Guided Tumor‐Selective Drug‐Delivery System to Treat Pancreatic Cancer (Adv. Mater. 46/2023)

Myrto Ischyropoulou(Max Planck Institute of Experimental Medicine), Frauke Alves(Max Planck Institute of Experimental Medicine), Kristina Sabljo(Karlsruhe Institute of Technology), Joanna Napp(Max Planck Institute of Experimental Medicine), Christof M. Niemeyer(Karlsruhe Institute of Technology), Leonie Schneider(Karlsruhe Institute of Technology), Claus Feldmann(Karlsruhe Institute of Technology)
Advanced Materials
November 1, 2023
10.1002/adma.202370334
Cited by 0

Related Papers

Diverse Applications of Nanomedicine
|ACS Nano|2017|1.3k
Ionic Liquids: New Perspectives for Inorganic Synthesis?
|Angewandte Chemie International Edition|2011|313
Targeted Luminescent Near-Infrared Polymer-Nanoprobes for In Vivo Imaging of Tumor Hypoxia
|Analytical Chemistry|2011|132
High‐Load Gemcitabine Inorganic–Organic Hybrid Nanoparticles as an Image‐Guided Tumor‐Selective Drug‐Delivery System to Treat Pancreatic Cancer
|Advanced Materials|2023|35
Dicarbonyl <i>cis</i>-[M(CO)<sub>2</sub>(N,O)(C)(P)] (M = Re, <sup>99m</sup>Tc) Complexes with a New [2 + 1 + 1] Donor Atom Combination
|Inorganic Chemistry|2018|24